BALCAO · SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC · SMALL CAP
Elite Health Systems Inc. EHSI
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$1.0M
EPS · FY25
—
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-164.5%
Net margin · FY25
-762.1%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.0M
Revenue, FY2025 · full 17-year series below
Revenue
Net income
The company lost 762 cents on every revenue dollar this year.
Per share
—
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-164.5%
Return on equity, FY2025
ROE
Operating margin-374.9%
Net margin-762.1%
Return on assets-142.1%
Each USD of equity lost 164 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
−20.2% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−20.2%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.03B
Shares outstanding, FY2025
Change, 5 years+19.2%
Change, 10 years+19.1%
The share count grew 19% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 6.7M
total assets, end of FY2025
Total assetsUSD 6.7M
EquityUSD 5.3M
CashUSD 3.8M
Current ratio3.35×
Equity funds 80% of total assets.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
·
·
·
·
·
·
·
·
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
EBITDA $B
−0.0
·
·
·
·
·
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
Income tax $B
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
EPS, diluted $
·
·
−0.17
−0.17
−0.11
0.07
0.02
−0.05
0.07
0.07
0.05
0.07
−0.09
0.09
0.00
0.06
0.01
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−164.5
−85.2
−86.6
−70.1
−28.1
15.6
4.6
−13.1
17.0
20.4
18.3
33.4
−38.5
42.8
2.2
43.7
9.0
Shares out B
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
49 of 49
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed